The small print

1.  Results are based on the STEP 1 Wegovy trial. Results vary – weight loss can be more or less than the 15% average.

Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" New England Journal of Medicine, 384(11)

https://doi.org/10.1056/NEJMoa2032183

2. Wilding, J.P.H. et al. (2022) "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension" Diabetes, Obesity and Metabolism, 24(8)

https://doi.org/10.1111/dom.14725

* Price may increase or decrease subject to market conditions.

** An admin fee may apply for early cancellation. See our terms and conditions.

*** Terms and conditions apply.

**** Coming soon.

***** Maximum of one consultation per week with no carry-over of unused appointments.